Nine Chapters Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-19,171
Closed -$88K 190
2017
Q1
$88K Sell
19,171
-7,215
-27% -$24.2K 0.12% 204
2016
Q4
$57K Buy
26,386
+21,800
+475% +$51K 0.1% 159
2016
Q3
$14K Buy
+4,586
New +$12.3K 0.1% 70
2015
Q4
Sell
-9,171
Closed -$65K 584
2015
Q3
$65K Buy
9,171
+5,914
+182% +$49.4K 0.01% 935
2015
Q2
$30K Sell
3,257
-700
-18% -$6.73K ﹤0.01% 921
2015
Q1
$37K Buy
+3,957
New +$38.1K ﹤0.01% 934
2014
Q2
Sell
-6,129
Closed -$82K 1158
2014
Q1
$82K Buy
+6,129
New +$80.7K 0.01% 771
2013
Q3
Sell
-3,329
Closed -$30K 936
2013
Q2
$30K Buy
+3,329
New +$34.9K 0.01% 610

Other funds holding CDMO

Nine Chapters Capital Management's CDMO Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2017, closing a stake of 19,171 shares — an estimated $88K sold.

Nine Chapters Capital Management first reported a position in CDMO in Q2 2013 and held it in 8 quarters. The position peaked at $88K in Q1 2017. 60 funds tracked by Wall St. Rank hold CDMO as of Q2 2017.

  • Nine Chapters Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Nine Chapters Capital Management sold 19,171 Avid Bioservices, Inc. Common Stock shares in Q2 2017, an estimated $88K.
  • Nine Chapters Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
  • Nine Chapters Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $88K in Q1 2017.
  • 60 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.